|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Non-invasive assessment of liver fibrosis in chronic hepatitis B显示文摘The goal of this review is to provide a comprehensive picture of the role,clinical applications and future perspectives of the most widely used non-invasive techniques for the evaluation of hepatitis B virus(HBV)infection.During the past decade many non-invasive methods have been developed to reduce the need for liver biopsy in staging fibrosis and to overcome whenever possible its limitations,mainly:invasiveness,costs,low reproducibility,poor acceptance by patients.Elastographic techniques conceived to assess liver stiffness,in particular transient elastography,and the most commonly used biological markers will be assessed against their respective role and limitations in staging hepatic fibrosis.Recent evidence highlights that both liver stiffness and some bio-chemical markers correlatewith survival and major clinical end-points such as liver decompensation,development of hepatocellular carcinoma and portal hypertension.Thus the non-invasive techniques here discussed can play a major role in the management of patients with chronic HBV-related hepatitis.Given their prognostic value,transient elastography and some bio-chemical markers can be used to better categorize patients with advanced fibrosis and cirrhosis and assign them to different classes of risk for clinically relevant outcomes.Very recent data indicates that the combined measurements of liver and spleen stiffness enable the reliable prediction of portal hypertension and esophageal varices development. | Federica Branchi Clara Benedetta Conti Alessandra Baccarin Pietro Lampertico Dario Conte Mirella Fraquelli | 2014 | World Journal of Gastroenterology2014，20，40： | 20 |
| 2 | 拉米夫定耐药治疗新概念:单药还是联合治疗显示文摘拉米夫定是首个用于治疗慢性乙型肝炎的核苷类药物,至今已有十余年历史,该药对延缓慢性乙型肝炎患者疾病的进展起明显作用,但长期应用拉米夫定治疗过程中耐药性的产生大大降低了该药的长期疗效。意大利Lampertico教授于2007年9月23日在上海用详实的数据向国内专家介绍了最近有关拉米夫定耐药治疗的新概念,特别是有关联合治疗还是单药治疗的问题上,改变了过去的看法。 | Pietro Lampertico 孙剑 侯金林 | 2008 | 肝脏2008，13，1： | 8 |
| 3 | Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy显示文摘 | George V. Papatheodoridis Henry Lik-Yuen Chan Bettina E. Hansen Harry L.A. Janssen Pietro Lampertico | 2015 | Journal of Hepatology2015，，4： | 3 |
| 4 | Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues显示文摘 | Carolina Boni Diletta Laccabue Pietro Lampertico Tiziana Giuberti Mauro Viganò Simona Schivazappa Arianna Alfieri Marco Pesci Giovanni B. Gaeta Giuseppina Brancaccio Massimo Colombo Gabriele Missale Carlo Ferrari | 2012 | Gastroenterology2012，，4： | 3 |
| 5 | Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review显示文摘 | George V. Papatheodoridis Pietro Lampertico Spilios Manolakopoulos Anna Lok | 2010 | Journal of Hepatology2010，，2： | 3 |
| 6 | Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C显示文摘 | Mirella Fraquelli Cristina Rigamonti Giovanni Casazza Maria Francesca Donato Guido Ronchi Dario Conte Mariagrazia Rumi Pietro Lampertico Massimo Colombo | 2010 | Journal of Hepatology2010，，4： | 3 |
| 7 | Liver transplantation for HBV-related cirrhosis in Europe: An ELTR study on evolution and outcomes显示文摘 | Patrizia Burra Giacomo Germani Renè Adam Vincent Karam Alfredo Marzano Pietro Lampertico Mauro Salizzoni Franco Filipponi Jurgen L. Klempnauer Denis Castaing Murat Kilic Luciano De Carlis Peter Neuhaus Sezai Yilmaz Andreas Paul Antonio D. Pinna Andrew K. | 2012 | Journal of Hepatology2012，，： | 2 |
| 8 | Optimal management of hepatitis B virus infection – EASL Special Conference显示文摘 | Pietro Lampertico Mala Maini George Papatheodoridis | 2015 | Journal of Hepatology2015，，5： | 2 |
| 9 | Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: An international multicenter cohort study显示文摘 | Jorg Petersen Vlad Ratziu Maria Buti Harry L.A. Janssen Ashley Brown Pietro Lampertico Jan Schollmeyer Fabien Zoulim Heiner Wedemeyer Martina Sterneck Thomas Berg Christoph Sarrazin Marc Lutgehetmann Peter Buggisch | 2011 | Journal of Hepatology2011，，3： | 2 |
| 10 | Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management显示文摘 | Mauro Viganò Elisabetta Degasperi Alessio Aghemo Pietro Lampertico Massimo Colombo | 2012 | Expert Opinion on Biological Therapy2012，，： | 2 |
| 11 | Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine显示文摘 | DiMarco V Marzano A Lampertico P | 2004 | Hepatology2004，40，5： | 1 |
| 12 | Development and application of an in vitro model for screening anti-hepatitis B virus therapeutics 显示文摘 | Lampertico P Maher J S Gerber M A | 1991 | Hepatology1991，13，3： | 1 |
| 13 | Long -term outcome of hepatitis B in lamivudine-resistant cirrhotic patients显示文摘 | Lampertico P Vigano M Romeo R | 2002 | J Hepatol2002，，： | 1 |
| 14 | Long-Term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy显示文摘 | Pietro Lampertico Ersilio Del Ninno Mauro Viganò Raffaella Romeo Maria Francesca Donato Erwin Sablon Alberto Morabito Massimo Colombo | 2003 | Hepatology2003，，4： | 1 |
| 15 | Development and application of an in vitro model for screening anti-hepatitis B virus therapeutics显示文摘 | Lampertico P Malter JS Gerber MA | 1991 | Hepatology1991，13，3： | 1 |
| 16 | Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistance hepatitis B patients显示文摘 | Lampertico P Vigano M Manenti E | 2007 | Gastroenterology2007，133，5： | 1 |
| 17 | A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum显示文摘 | Lampertico P Del Ninno E manzin A | 1997 | Hepatology1997，26，： | 1 |
| 18 | Restoredfunction of HBV - specific T cells after long - term effectivetherapy with nucleos(t) ide analogues显示文摘 | BONI C LACCABUE D LAMPERTICO P | 2012 | Gastroenterolo-gy2012，143，4： | 1 |
| 19 | Long-term outcome of hepatitis B in lamivudine-resistant cirrhotic patients显示文摘 | LAMPERTICO P VIGANO M ROMEO R | 2002 | J Hepatol2002，36，1： | 1 |
| 20 | Low resistance to adefovir combined with lamivudine 3-year study of 145 lamivudine-resistant hepatitis B patients显示文摘 | Lampertico P Vigano M Manenti E et a! | 2007 | Gastroenterology2007，133，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员